Release of soluble tumor necrosis factor receptors in Mediterranean spotted fever rickettsiosis

被引:13
作者
Kern, WV
Oristrell, J
SeguraPorta, F
Kern, P
机构
[1] UNIV HOSP & MED CTR, SECT INFECT DIS & CLIN IMMUNOL, D-89070 ULM, GERMANY
[2] SABADELL HOSP, DEPT INTERNAL MED, E-08208 SABADELL, BARCELONA, SPAIN
[3] SABADELL HOSP, PROGRAM INFECT DIS, E-08208 SABADELL, BARCELONA, SPAIN
关键词
D O I
10.1128/CDLI.3.2.233-235.1996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor necrosis factor alpha (TNF) is a key cytokine in the defense against many intracellular pathogens, including Rickettsia conorii, the causative agent of Mediterranean spotted fever (MSF). The levels of two soluble TNF receptors (sTNFR-p55 and sTNFR-p75), the extracellular domains of the two cell surface receptors for TNF, were elevated in the acute-stage plasma samples from 20 patients with serologically confirmed MSF. The median values were 3.1 and 7.8 ng/ml for sTNFR-p55 and sTNFR-p75, respectively. sTNFR values correlated significantly with plasma TNF concentrations. Patients with severe MSF had higher values for both receptor fragments than patients with nonsevere disease. The differences were statistically significant for sTNFR-p55 (median, 5.8 versus 2.0 ng/ml; P = 0.008), Given the proportionately higher values for both TNF and sTNFR-p55 in patients with severe MSF, the sTNFR-p55/TNF ratios for the two patient subgroups did not differ (P = 0.5), while the sTNFR-p75/TNF ratios were significantly different (P = 0.01), with disproportionately lower values in patients with severe disease.
引用
收藏
页码:233 / 235
页数:3
相关论文
共 21 条
[1]  
ANKRUST P, 1994, J INFECT DIS, V169, P420
[2]  
ENGELMANN H, 1990, J BIOL CHEM, V265, P14497
[3]  
FENG HM, 1993, AM J PATHOL, V142, P1471
[4]   DEPLETION OF GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR-ALPHA IN MICE WITH RICKETTSIA CONORII-INFECTED ENDOTHELIUM - IMPAIRMENT OF RICKETTSICIDAL NITRIC-OXIDE PRODUCTION RESULTING IN FATAL, OVERWHELMING RICKETTSIAL DISEASE [J].
FENG, HM ;
POPOV, VL ;
WALKER, DH .
INFECTION AND IMMUNITY, 1994, 62 (05) :1952-1960
[5]  
GIRARDIN E, 1992, IMMUNOLOGY, V76, P20
[6]   SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS IN PLASMODIUM-VIVAX MALARIA [J].
KERN, P ;
KERN, WV ;
KREMSNER, P .
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (05) :1340-1341
[7]   SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTORS CORRELATE WITH PARASITEMIA AND DISEASE SEVERITY IN HUMAN MALARIA [J].
KERN, P ;
HEMMER, CJ ;
GALLATI, H ;
NEIFER, S ;
KREMSNER, P ;
DIETRICH, M ;
PORZSOLT, F .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (04) :930-934
[8]   CIRCULATING TUMOR-NECROSIS-FACTOR-ALPHA (TNF), SOLUBLE TNF RECEPTORS, AND INTERLEUKIN-6 IN HUMAN SUBACUTE BACTERIAL-ENDOCARDITIS [J].
KERN, WV ;
ENGEL, A ;
SCHIEFFER, S ;
PRUMMER, O ;
KERN, P .
INFECTION AND IMMUNITY, 1993, 61 (12) :5413-5416
[9]   PATTERNS OF PROINFLAMMATORY CYTOKINES AND INHIBITORS DURING TYPHOID-FEVER [J].
KEUTER, M ;
DHARMANA, E ;
GASEM, MH ;
VANDERVENJONGEKRIJG, J ;
DJOKOMOELJANTO, R ;
DOLMANS, WMV ;
DEMACKER, P ;
SAUERWEIN, R ;
GALLATI, H ;
VANDERMEER, JWM .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) :1306-1311
[10]   TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA)-INDUCED CELL-ADHESION TO HUMAN ENDOTHELIAL-CELLS IS UNDER DOMINANT CONTROL OF ONE TNF RECEPTOR TYPE, TNF-R55 [J].
MACKAY, F ;
LOETSCHER, H ;
STUEBER, D ;
GEHR, G ;
LESSLAUER, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (05) :1277-1286